相关实验视频

Updated: Feb 22, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

缺血性中风患者的静脉血栓溶解与垂体瘤:全国性的研究和范围审查

Matthew K McIntyre¹, Huanwen Chen^2,3, Dheeraj Gandhi³

¹Department of Neurological Surgery, Oregon Health & Science University, Portland, OR 97239, USA.

|February 20, 2026

概括

内静脉血栓溶解 (IVT) 对于患有垂体瘤的急性缺血性中风 (AIS) 显示了改善的功能结果,而没有增加风险. 这项研究强调了对这种罕见的患者群体需要更多数据的需求.

科学领域:

神经学神经学
神经外科神经外科
血管神经学血管神经学

背景情况:

静脉血栓溶解 (IVT) 治疗急性缺血性中风 (AIS) 的安全性在患有垂体瘤的患者中尚未得到充分证实.
垂体瘤在中风管理中具有独特的挑战,因为它们的位置和并发症的可能性.

研究的目的:

评估IVT在AIS患者的安全性和有效性.
在这个特定的患者群体中,比较IVT与不IVT的结果.
为了评估AIS患者的结局与那些没有的同比下垂体瘤.

主要方法:

进行了PubMed,Scopus,EMBASE和Web of Science的综合文献审查.
对2016年至2022年的全国再接收数据库 (NRD) 进行了回顾性分析.
分析的结果包括功能状态,内出血 (ICH),死亡率和脑垂体脑梗塞,以多变量回归为混调整.

主要成果:

文献审查发现只有5名AIS患者患有垂体瘤;60%的患者经历了ICH,没有人患有中风.
在全国范围内对1,246,750名AIS患者的分析显示,有1661名 (0.13%) 患有垂体瘤.
在这个队列中,IVT与更高的功能独立率 (aOR 2.46) 相关,而没有增加ICH或死亡风险;没有观察到垂体脑梗塞.

结论:

有关IVT在AIS患者中使用的临床数据显著缺乏.
在美国一大群患有下垂体瘤的AIS患者中,IVT的使用与改善住院结果有关.
在这组患者中,没有观察到IVT增加内出血或垂体脑梗塞的风险.

关键词:

在TNK中,TNK是TNK.在 TPA TPA 中.发生出血发生出血静脉内血栓溶解是一种静脉内血栓溶解.pituitary 瘤发生在 pituitary 瘤中.一次性中风中风中风中风中风

更多相关视频

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

相关概念视频

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

Pulmonary Embolism III: Nursing Management

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...